Djordje Djordjevic, PhD (Co-founder and CEO), a seasoned bioinformatics specialist previously with the Novo Nordisk Cell Therapy Unit, combines his understanding of the industry's commercial demands and patient-centric focus with deep technical expertise and data-driven approaches to solve major challenges in advanced therapies. Djordje developed bioinformatics platforms for drug discovery and improving stem cell therapies while at Novo Nordisk, has co-authored over 20 peer-reviewed scientific publications and is listed as an inventor on 4 published patents.